Pharmerica Cash Flow - Quarterly (NYSE:PMC)

Add to My Stocks
$29.25 $0.05 (0.17%) PMC stock closing price Dec 07, 2017 (Closing)

The Pharmerica cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows Pharmerica profits, the balance sheet shows Pharmerica debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Pharmerica saw a cash impact of $- from the buyback of PMC shares. The cash flow statement helps in the Pharmerica stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Pharmerica saw a outflow of $-117.4M from investing activities till 2017 Q3.

View and download details of Pharmerica cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow49.9M33.1M16.2M58.1M42.3M27.7M13.6M52.3M
Net Increase (Decrease) in Assets Liabilities55.7M61.3M47.09M-64.39M9.6M-5.1M40M-80.3M
Cash From (used in) Discontinued Operations--------
Other Adjustments Net15.7M12.1M5.4M15.5M14.5M12M4.6M11.4M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-23.4M-15.9M-7.9M-34.1M-26.2M-13.3M-5.4M-23.8M
Acquisition Disposition of Subsidiaires-94M-50.7M-48.2M-57.6M-31.3M-6.9M-6.7M-83.6M
Increase (Decrease) in Investments--------
Other Cash Inflow (Outflow) from Investment Activities-------3.3M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----3.1M-3.1M-2.9M-2.9M-3.5M
Issuance (Repayment) of Debt Securities-13.6M-40.8M-6.9M46.8M-36.3M-5.8M-47.9M76.5M
Increase (Decrease) in Bank & Other Borrowings------8M--
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities-0.1M---0.5M--3M2.4M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year33.3M24.2M12.3M17.4M10.8M51.2M41.3M32M
Cash & Equivalents at Year End7.8M13.5M15.4M5.4M6.5M27.4M25.5M23.1M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Pharmerica stock price history provides the price history of a stock, Pharmerica stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Pharmerica has cash of $7.8M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Pharmerica stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $132.7M for PMC.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-117.4M for PMC stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Pharmerica and its owners and creditors and was $-12.9M till 2017 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Pharmerica Cash Flow

FCF margin